Azure Holdings PLC
03 October 2006
Azure Holdings plc
(the 'Company')
First Day of Dealings on AIM
Following the approval of the special resolutions at the Extraordinary General
Meeting ('EGM') and Class Meetings held yesterday, the Company announces the
admission, in aggregate, of 885,191,389 ordinary shares of 0.2p each ('Ordinary
Shares') to trading on AIM today.
At the EGM, Barry Gold resigned as a director of the Company. Anthony Moore was
appointed Non-executive Chairman; Dr Satu Vainikka was appointed Chief
Executive; Dr Jacob Micallef was appointed Chief Operating Officer; Dr George
Morris was appointed Chief Development Officer and Kevin Alexander was appointed
as a Non-executive Director of the Company. Gerald Desler remains as Finance
Director.
The Company's name is expected to change to ValiRx plc effective from 4 October
2006.
Anthony Moore, Non-executive Chairman, ValiRx plc, commented:
'I am delighted that the reverse transaction into Azure Holdings plc has
completed and the enlarged group is quoted on AIM. I believe that the Company
has some exciting products and I look forward to their development and
anticipate regular positive newsflow.'
For further information, please contact:
ValiRx plc
Anthony Moore
Dr Satu Vainikka
Tel: 0207 408 5400
WH Ireland Limited
David Youngman
Tel: 0161 832 2174
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.